ANIX
Anixa Biosciences Inc
NASDAQ: ANIX · HEALTHCARE · BIOTECHNOLOGY
$3.00
+4.17% today
Updated 2026-04-30
Market cap
$100.58M
P/E ratio
—
P/S ratio
377.78x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$10.75
+258.33%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.61M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.47B | $210000.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-13.60M | $-9.81M | $-12.55M | $-10.93M | $-2.56M |
| EPS | — | — | — | — | $-0.32 |
| Free cash flow | $-6.49M | $-6.21M | $-7.33M | $-7.17M | $-2.61M |
| Profit margin | -0.55% | -4,671.90% | — | — | — |
Peer comparison
Smart narrative
Anixa Biosciences Inc trades at $3.00. Our Smart Value Score of 17/100 indicates the stock is weak.
Frequently asked questions
What is Anixa Biosciences Inc's stock price?
Anixa Biosciences Inc (ANIX) trades at $3.00.
Is Anixa Biosciences Inc overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of Anixa Biosciences Inc (ANIX)?
The analyst target price is $10.75, representing +258.3% upside from the current price of $3.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio377.78x
ROE-68.10%
Beta0.58
50D MA$2.84
200D MA$3.37
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—